Кагоцел® - противовирусный препарат для профилактики и лечения гриппа и ОРВИ у взрослых и детей с 3-х лет

Kagocel Ranked No. 1 OTC Drug, Showed Greatest Impact on the Pharma Market in 2016

The Romir holding elaborated a 2016 influence rating for the pharmaceutical market based on the results of an expert survey, and then, in cooperation with the KPMG consulting company, determined winners in each nomination. The sample size in this study amounted to 476 experts from 26 cities located in all federal districts of the Russian Federation. The sample group included directors and heads of pharmacies, procurement managers, representatives of Russian and foreign manufacturers of pharma products, pharmacists, representatives of distribution companies, representatives of academia and expert community, and civil servants. In the ranking of OTC drugs, Kagocel took the first place. 

 Source: Pharmaceutical Bulletin No.5

← Back to the list